APRE earnings

Aprea Therapeutics (APRE) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.

APRE earnings history

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026Nov 4, 2026-0.09-0.07-24.14%–
Q2 2026Aug 12, 2026-0.07-0.1860.56%–
Q1 2026May 13, 2026-0.22-0.234.35%$140.50K
Q4 2025Mar 16, 2026-0.32-0.3815.79%$3.34K
Q3 2025Nov 12, 2025-0.47-0.11-327.27%$1.85K
Q2 2025Aug 12, 2025-0.53-0.7731.17%$118.11K
Q1 2025May 14, 2025-0.66-0.65-0.87%$162.46K
Q4 2024Mar 25, 2025-0.49-0.6928.99%$205.82K
Q3 2024Nov 7, 2024-0.64-0.7514.67%$354.62K
Q2 2024Aug 12, 2024-0.58––$561.57K
Q1 2024May 14, 2024-0.67-0.7814.10%$380.57K
Q4 2023Mar 26, 2024-0.92––$14.07K
Q3 2023Nov 9, 2023-0.86––$319.47K
Q2 2023Aug 10, 2023-0.87-1.4339.16%$249.69K
Q1 2023May 15, 2023-1.34-1.5111.26%–
Q4 2022Mar 30, 2023-0.92-2.6064.62%–
Q3 2022Nov 9, 2022-2.40-5.6057.14%–